These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26024828)

  • 1. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.
    Calkins KL; Havranek T; Kelley-Quon LI; Cerny L; Flores M; Grogan T; Shew SB
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):404-411. PubMed ID: 26024828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.
    Nehra D; Fallon EM; Carlson SJ; Potemkin AK; Hevelone ND; Mitchell PD; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):498-505. PubMed ID: 22767698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study.
    Rollins MD; Ward RM; Jackson WD; Mulroy CW; Spencer CP; Ying J; Greene T; Book LS
    J Pediatr Surg; 2013 Jun; 48(6):1348-56. PubMed ID: 23845629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental Parenteral Vitamin E Into Conventional Soybean Lipid Emulsion Does Not Prevent Parenteral Nutrition-Associated Liver Disease in Full-Term Neonatal Piglets.
    Muto M; Lim D; Soukvilay A; Field C; Wizzard PR; Goruk S; Ball RO; Pencharz PB; Mi S; Curtis J; Wales PW; Turner JM
    JPEN J Parenter Enteral Nutr; 2017 May; 41(4):575-582. PubMed ID: 26471989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral nutrition-associated cholestasis and triglyceridemia in surgical term and near-term neonates: A pilot randomized controlled trial of two mixed intravenous lipid emulsions.
    Pereira-da-Silva L; Nóbrega S; Rosa ML; Alves M; Pita A; Virella D; Papoila AL; Serelha M; Cordeiro-Ferreira G; Koletzko B
    Clin Nutr ESPEN; 2017 Dec; 22():7-12. PubMed ID: 29415837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
    Cober MP; Teitelbaum DH
    Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.
    Ng K; Stoll B; Chacko S; Saenz de Pipaon M; Lauridsen C; Gray M; Squires EJ; Marini J; Zamora IJ; Olutoye OO; Burrin DG
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):656-71. PubMed ID: 25596209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
    Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC
    Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates.
    Levit OL; Calkins KL; Gibson LC; Kelley-Quon L; Robinson DT; Elashoff DA; Grogan TR; Li N; Bizzarro MJ; Ehrenkranz RA
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):374-82. PubMed ID: 24963025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M; Valim C; Meisel JA; Le HD; de Meijer VE; Robinson EM; Zhou J; Duggan C; Gura KM
    Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Parenteral Nutrition-Associated Liver Disease and Other Adverse Effects in Neonates Receiving SMOFlipid or Intralipid.
    Stramara L; Hernandez L; Bloom BT; Durham C
    JPEN J Parenter Enteral Nutr; 2020 Nov; 44(8):1530-1534. PubMed ID: 32027047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
    Fallon EM; Le HD; Puder M
    Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Parenteral Nutrition-associated Cholestasis Using Reduced Dose Soybean Lipid Emulsion: A Multicenter Randomized Trial.
    Maselli KM; Carter IC; Matusko N; Warschausky S; Blackmer AB; Islam S; Rollins MD; Javid PJ; Arnold MA
    J Pediatr Surg; 2024 Jul; 59(7):1369-1373. PubMed ID: 38614946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMOFlipid vs Intralipid 20%: Effect of Mixed-Oil vs Soybean-Oil Emulsion on Parenteral Nutrition-Associated Cholestasis in the Neonatal Population.
    Jackson RL; White PZ; Zalla J
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):339-346. PubMed ID: 32391595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Complications Associated with Parenteral Nutrition in Preterm Infants < 32 Weeks with a Mixed Oil Lipid Emulsion vs a Soybean Oil Lipid Emulsion in a Level IV Neonatal Intensive Care Unit.
    Franco S; Goriacko P; Rosen O; Morgan-Joseph T
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1204-1212. PubMed ID: 32862507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of parenteral fat composition on cholestasis in preterm infants.
    Teng J; Arnell H; Bohlin K; Nemeth A; Fischler B
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):702-7. PubMed ID: 25633496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions.
    Skouroliakou M; Konstantinou D; Agakidis C; Delikou N; Koutri K; Antoniadi M; Karagiozoglou-Lampoudi T
    Nutr Clin Pract; 2012 Dec; 27(6):817-24. PubMed ID: 22878361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors derived from parenteral nutrition associated with cholestasis in 612 neonates].
    Tang QY; Wang Y; Feng Y; Tao YX; Wu J; Cai W
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):838-42. PubMed ID: 18282416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.